MIAMI--(BUSINESS WIRE)--ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the �Company�), a fully integrated in vitro diagnostics company, announced today that, on May 17, 2013, the Company received a letter from NYSE MKT LLC (the �Exchange�) stating that ...

ERBA Diagnostics, Inc. (NYSE MKT: ERB), a fully integrated in vitro diagnostics company, is pleased to announce its participation at the Euromedlab conference in Milan, Italy, May 19th thru May 23rd.

ERBA Diagnostics (NYSE MKT:ERB) headquartered in Miami, Florida, is a fully integrated in vitro diagnostics company that develops, manufactures and distributes in the United States and internationally, proprietary diagnostic reagents, test kits and ...